Publicaciones en colaboración con investigadores/as de University of Innsbruck (7)

2022

  1. Trial of Prasinezumab in Early-Stage Parkinson's Disease

    New England Journal of Medicine, Vol. 387, Núm. 5, pp. 421-432

2021

  1. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

2019

  1. Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 11, pp. 301-309

2018

  1. Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients

    Parkinsonism and Related Disorders, Vol. 52, pp. 83-89

2017

  1. Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration

    Movement Disorders Clinical Practice, Vol. 4, Núm. 4, pp. 536-544

2015

  1. Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

    Parkinsonism and Related Disorders, Vol. 21, Núm. 10, pp. 1133-1144

2014

  1. Perceptual decision-making in patients with Parkinson's disease

    Journal of Psychopharmacology, Vol. 28, Núm. 12, pp. 1149-1154